Relevance of the Anti-Inflammatory Properties of Curcumin in Neurodegenerative Diseases and Depression

被引:60
作者
Tizabi, Yousef [1 ]
Hurley, Laura L. [1 ]
Qualls, Zakiya [1 ]
Akinfiresoye, Luli [1 ]
机构
[1] Howard Univ, Coll Med, Dept Pharmacol, Washington, DC 20059 USA
关键词
curcumin; inflammation; depression; Parkinson's disease; neuroprotection; NIGRAL DOPAMINERGIC-NEURONS; PRO-INFLAMMATORY CYTOKINES; PARKINSONS-DISEASE; RAT MODEL; ALZHEIMERS-DISEASE; MAJOR DEPRESSION; HUMAN BRAINS; ANTIDEPRESSANT TREATMENT; PSYCHOLOGICAL STRESS; ANTIOXIDANT ACTIVITY;
D O I
10.3390/molecules191220864
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review is an attempt to summarize our current understanding of curcumin's potential as a neuroprotectant and an antidepressant. This dual property confers a unique advantage to this herbal medication, believed to be devoid of any major side effects, to combat commonly observed co-morbid conditions of a neurodegenerative and a neuropsychiatric disorder. Moreover, in line with the theme of this series, the role of inflammation and stress in these diseases and possible anti-inflammatory effects of curcumin, as well as its interaction with signal transduction proteins as a common denominator in its varied mechanisms of action, are also discussed. Thus, following a brief introduction of curcumin's pharmacology, we present research suggesting how its anti-inflammatory properties have therapeutic potential in treating a devastating neurological disorder (Parkinson's disease = PD) and a debilitating neuropsychiatric disorder (major depressive disorder = MDD). It is concluded that curcumin, or better yet, an analog with better and longer bioavailability could be of important therapeutic potential in PD and/or major depression.
引用
收藏
页码:20864 / 20879
页数:16
相关论文
共 139 条
  • [41] Curcumin and Alzheimer's Disease
    Hamaguchi, Tsuyoshi
    Ono, Kenjiro
    Yamada, Masahito
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (05) : 285 - 297
  • [42] HARTLEY A, 1994, J NEUROCHEM, V63, P1987
  • [43] The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity
    Hayley, S
    Poulter, MO
    Merali, Z
    Anisman, H
    [J]. NEUROSCIENCE, 2005, 135 (03) : 659 - 678
  • [44] Stress, depression and Parkinson's disease
    Hemmerle, Ann M.
    Herman, James P.
    Seroogy, Kim B.
    [J]. EXPERIMENTAL NEUROLOGY, 2012, 233 (01) : 79 - 86
  • [45] Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
    Howren, M. Bryant
    Lamkin, Donald M.
    Suls, Jerry
    [J]. PSYCHOSOMATIC MEDICINE, 2009, 71 (02): : 171 - 186
  • [46] Neuroinflammation, Neurodegeneration, and Depression
    Hurley, Laura L.
    Tizabi, Yousef
    [J]. NEUROTOXICITY RESEARCH, 2013, 23 (02) : 131 - 144
  • [47] Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF
    Hurley, Laura L.
    Akinfiresoye, Luli
    Nwulia, Evaristus
    Kamiya, Atsushi
    Kulkarni, Amol A.
    Tizabi, Yousef
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2013, 239 : 27 - 30
  • [48] IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation
    Hurst, SM
    Wilkinson, TS
    McLoughlin, RM
    Jones, S
    Horiuchi, S
    Yamamoto, N
    Rose-John, S
    Fuller, GM
    Topley, N
    Jones, SA
    [J]. IMMUNITY, 2001, 14 (06) : 705 - 714
  • [49] Ishikawa I, 2001, JPN J VET RES, V49, P19
  • [50] Jurenka JS, 2009, ALTERN MED REV, V14, P141